Autopsy report · NCT02511041
Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 7 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Sponsor type
- US National Institutes of Health
- Conditions
- PGM3
- Interventions
- N-Acetylglucosamine (GlcNAc); Uridine
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.